Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

RVPH
Reviva Pharmaceuticals Holdings, Inc. Common Stock
stock NASDAQ

At Close
Dec 5, 2025 3:59:56 PM EST
0.6200USD+4.601%(+0.0272)4,422,616
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Dec 5, 2025 9:28:30 AM EST
0.6095USD+3.095%(+0.0183)150,684
After-hours
Dec 5, 2025 4:58:30 PM EST
0.6001USD-2.959%(-0.0183)42,229
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
10:05AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2022   Benzinga
06:08AM EST  HC Wainwright & Co. Initiates Coverage On Reviva Pharmaceuticals with Buy Rating, Announces Price Target of $10   Benzinga
Jan 16, 2022
04:02AM EST  RVPH: FDA Allows IND; Imminent Start to Phase III   Benzinga
Jan 10, 2022
06:24AM EST  Reviva Pharma Gets FDA Clearance To Proceed With Initiation Of Pivotal Phase 3 Trial Of Brilaroxazine For Schizophrenia   RTTNews
06:09AM EST  Reviva Pharmaceuticals Holdings, Inc. Receives FDA May Proceed Letter For Pivotal Phase 3 Clinical Trial And Long-Term Safety Trial Evaluating Brilaroxazine For The Treatment Of Schizophrenia   Benzinga
06:00AM EST  - Brilaroxazine is a novel serotonin and dopamine receptor modulator currently being developed for diseases with dysfunctional serotonin signaling including neuropsychiatric and pulmonary indications -   GlobeNewswire Inc
Dec 20, 2021
07:00AM EST  Reviva Pharmaceuticals to Participate in the Upcoming January   GlobeNewswire Inc
Nov 15, 2021
11:15AM EST  Reviva Pharmaceuticals Q3 EPS $(0.12)   Benzinga
08:15AM EST  -Initiation of a pivotal Phase 3 trial evaluating the efficacy and safety of brilaroxazine for the treatment of schizophrenia expected by year-end -   GlobeNewswire Inc
Sep 15, 2021
08:30AM EDT  Reviva Pharmaceuticals to Present at the   GlobeNewswire Inc
Sep 2, 2021
08:30AM EDT  Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd   GlobeNewswire Inc
Aug 29, 2021
05:21AM EDT  RVPH: Second Quarter Update   Benzinga
Aug 16, 2021
08:29AM EDT  Reviva Pharma Q2 Net Loss $2.6 Mln Or $0.23/Shr Vs Loss $1.6 Mln Or $0.58/Shr Last Year   RTTNews
08:18AM EDT  Reviva Pharmaceuticals Q2 EPS $(0.23) Up From $(0.58) YoY   Benzinga
08:15AM EDT  -Closed Underwritten Public Offering of Common Stock and Warrants Resulting in Gross Proceeds of $34.5 Million   GlobeNewswire Inc
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 26, 2021
10:05AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021   Benzinga
07:51AM EDT  Maxim Group Initiates Coverage On Reviva Pharmaceuticals with Buy Rating, Announces Price Target of $10   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jun 28, 2021
07:00AM EDT  Reviva Added to Russell Microcap Index   GlobeNewswire Inc
May 27, 2021
08:24AM EDT  The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs   Benzinga
May 26, 2021
08:48PM EDT  Reviva Announces Pricing Of Upsized $30 Mln Underwritten Public Offering   RTTNews
08:43PM EDT  Reviva Announces Pricing of Upsized $30 Million Underwritten   GlobeNewswire Inc
May 17, 2021
09:54AM EDT  Reviva: Developing Next-Generation Antipsychotic Drug   Benzinga
Apr 27, 2021
10:17AM EDT  Mid-Morning Market Update: Markets Edge Lower; General Electric Reports Mixed Q1 Results   Benzinga
Apr 26, 2021
02:30PM EDT  Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Reviva Pharmaceuticals Shares Spike Higher   Benzinga
12:19PM EDT  Mid-Day Market Update: Proofpoint Jumps Following Acquisition News; Fortuna Silver Mines Shares Slide   Benzinga
10:17AM EDT  Mid-Morning Market Update: Markets Rise; Lennox Beats Q1 Views   Benzinga
09:22AM EDT  Reviva Pharma Stock Trading Higher On Detailed Positive Schizophrenia Study Results   Benzinga
06:05AM EDT  Reviva Reports Phase 2 Clinical Trial Results for Acute Schizophrenia Met Endpoints For Safety And Efficacy In 234 Patients' And Met Primary Endpoint Of Reduction In Positive And Negative Syndrome Scale Total Score   Benzinga
06:00AM EDT  Reviva Announces Full Details of Positive Phase 2 Clinical Trial   GlobeNewswire Inc
Apr 16, 2021
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
Apr 15, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split   Benzinga
Apr 14, 2021
10:31AM EDT  RVPH: FY:20 Financial Results & RVPH5063 Comparison   Benzinga
07:51AM EDT  The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead   Benzinga
Apr 13, 2021
08:16AM EDT  The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug   Benzinga
Mar 26, 2021
04:39PM EDT  Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 25, 2021
07:58AM EDT  The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut   Benzinga
Mar 24, 2021
08:59AM EDT  The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping   Benzinga
Mar 23, 2021
08:18AM EDT  The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO   Benzinga
Mar 22, 2021
08:27AM EDT  -Closed Merger with Tenzing Acquisition Corp and publicly listed onNASDAQ Capital Market-   GlobeNewswire Inc
Mar 11, 2021
05:36PM EST  Reviva Pharmaceuticals Holdings, Inc. to Present at the Maxim   GlobeNewswire Inc
Mar 9, 2021
09:17AM EST  The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data   Benzinga
Mar 4, 2021
05:00PM EST  Reviva Pharmaceuticals to Present at the H.C. Wainwright Global   GlobeNewswire Inc
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 14, 2020
09:20AM EST  Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC